Treatment of Type II diabetes mellutis with amylin agonists
AssigneeAmylin Pharmaceuticals, Inc.
InventorsOrville G. Kolterman, Robert G. Thompson, John F. Mullane
Life of this patent
Estimating the term…
Abstract
Methods for treating non-insulin-taking Type II diabetes mellitus which comprise administering a therapeutically effective amount of an amylin agonist.
Claims21
A method for the treatment of a non-insulin-taking Type II diabetic subject comprising administering to said subject a therapeutically effective amount of an amylin agonist.
A method of lowering blood glucose in a non- insulin-taking Type II diabetic subject comprising administering to said subject a blood-glucose-lowering amount of an amylin agonist.
A method for the treatment of a non-insulin-taking Type II diabetic subject comprising administering to said subject a therapeutically effective amount of a medicine comprising .sup.25,28,29 Pry-h-amylin.
A method of lowering post-prandial blood glucose in a non-insulin-taking Type II diabetic subject comprising administering to said subject a post-prandial blood glucose lowering amount of an amylin agonist.
Dependencies are inferred from the claim text.